Smoking cessation after acute myocardial infarction, is relapse predictable?
More details
Hide details
Department of Cardiology. Cardiac rehabilitation Unit. University Hospital la Paz. Madrid. Spain
Regina Dalmau   

Department of Cardiology. Cardiac rehabilitation Unit. University Hospital la Paz. Madrid. Spain
Publication date: 2018-06-13
Tob. Prev. Cessation 2018;4(Supplement):A122
Taking into account the burden of tobacco in cardiovascular prognosis, smoking cessation should be a priority in secondary prevention programs. We analysed the predictors of relapse after a smoking cessation intervention in coronary disease patients.

448 smoker patients (85,5% male) referred to a cardiac rehabilitation program after a recent admission for acute myocardial infarction were analyzed. Most of them were heavy smokers (mean consumption of 24,5 cig/day, 41,2 pack-year). The intervention was based in an average of 3 individual visits during the first 3 months, one group session, and one follow-up visit after 6 months. Diet and exercise counselling was given. First line smoking cessation pharmacotherapy was offered to all patients as a possibility. Smoking abstinence was confirmed with co-oximetry at 3 and 6-month follow-up visits. A multivariate analysis was performed in order to study the predictors of relapse.

Mean age was 53.6, 57% were hypertensive, 23% diabetic, 60% dislipidaemic, 27% obese and 7% had been previously diagnosed with chronic obstructive pulmonary disease (COPD). Pharmacotherapy for smoking cessation was requested in 31%, varenicline was used in 57% of them, nicotine replacement therapy in 33% and bupropion in 10%. Patients lost to follow-up (3% at month 3, 6% at month 6) were considered as having relapsed. Abstinence rate was 76,6% at month 3, and 71% at month 6. Following a multivariate analysis, the predictors of relapse were found to be the number of cigarettes smoked per day, the number of pack-year, the use of smoking cessation drugs, dropping out of the program, and having a previous condition of COPD.

Smoking cessation interventions after an acute myocardial infarction are effective. A high degree of motivation facilitates the abstinence even in the absence of pharmacotherapy. A high degree of addiction and dependence, the need of smoking cessation drugs, lack of adherence and a previous condition of COPD were predictors of relapse. A more intense intervention is probably needed in patients with these features.

No conflict of interest. No external funding.